Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans

Leif C. Groop, Nir Barzilai, Klaus Ratheiser, Livio Luzi, Elisabeth Wåhlin-Boll, Arne Melander, Ralph A. DeFronzo

Research output: Contribution to journalArticle

77 Scopus citations

Abstract

Objective: To examine the relationship between plasma glyburide concentrations (0, 50, 100, 200, 400, and 800 nM) and the insulin response and glucose metabolism during euglycemic (4.6 ± 0.1 mM) and hyperglycemic (11.6 ± 0.2 mM) conditions. Research Design and Methods: Nine healthy subjects participated in the study. Steady-state plasma glyburide concentrations were achieved by primed continuous intravenous infusion of glyburide. Results: During both euglycemia and hyperglycemia, glyburide enhanced insulin secretion and glucose disposal only to drug levels of 100-200 nM corresponding to an oral dose ≤10 mg. Conclusions: The data suggest that glyburide (and probably other sulfonylureas) operates within a narrow range of plasma concentrations (50-200 nM), which can be achieved with very low doses of the drug. It remains to be shown whether the threshold of maximal effect also in clinical practice is achieved with lower sulfonylurea doses than that currently used.

Original languageEnglish (US)
Pages (from-to)724-727
Number of pages4
JournalDiabetes care
Volume14
Issue number8
DOIs
StatePublished - Aug 1991
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Fingerprint Dive into the research topics of 'Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans'. Together they form a unique fingerprint.

  • Cite this

    Groop, L. C., Barzilai, N., Ratheiser, K., Luzi, L., Wåhlin-Boll, E., Melander, A., & DeFronzo, R. A. (1991). Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. Diabetes care, 14(8), 724-727. https://doi.org/10.2337/diacare.14.8.724